Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Bortezomib

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Crickx E, et al. Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience. British Journal of Haematology 202 : 883-889, No. 4, Aug 2023. Available from: URL: http://doi.org/10.1111/bjh.18893 Crickx E, et al. Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience. British Journal of Haematology 202 : 883-889, No. 4, Aug 2023. Available from: URL: http://​doi.​org/​10.​1111/​bjh.​18893
Metadaten
Titel
Bortezomib
Lack of efficacy: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47150-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Quetiapine

Case report

Brolucizumab

Case report

Multiple drugs

Case report

Azathioprine